These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

450 related items for PubMed ID: 23522185

  • 21. N3-substituted temozolomide analogs overcome methylguanine-DNA methyltransferase and mismatch repair precipitating apoptotic and autophagic cancer cell death.
    Zhang J, Hummersone M, Matthews CS, Stevens MF, Bradshaw TD.
    Oncology; 2015; 88(1):28-48. PubMed ID: 25277441
    [Abstract] [Full Text] [Related]

  • 22. Synergistic Suppression of Glioblastoma Cell Growth by Combined Application of Temozolomide and Dopamine D2 Receptor Antagonists.
    Liu Z, Jiang X, Gao L, Liu X, Li J, Huang X, Zeng T.
    World Neurosurg; 2019 Aug; 128():e468-e477. PubMed ID: 31048057
    [Abstract] [Full Text] [Related]

  • 23. Antitumor effect of fibrin glue containing temozolomide against malignant glioma.
    Anai S, Hide T, Takezaki T, Kuroda J, Shinojima N, Makino K, Nakamura H, Yano S, Kuratsu J.
    Cancer Sci; 2014 May; 105(5):583-91. PubMed ID: 24673719
    [Abstract] [Full Text] [Related]

  • 24. Are There Thresholds in Glioblastoma Cell Death Responses Triggered by Temozolomide?
    He Y, Kaina B.
    Int J Mol Sci; 2019 Mar 28; 20(7):. PubMed ID: 30925722
    [Abstract] [Full Text] [Related]

  • 25. Human Glioma Cells Acquire Temozolomide Resistance After Repeated Drug Exposure Via DNA Mismatch Repair Dysfunction.
    Yamashiro K, Nakao K, Ohba S, Hirose Y.
    Anticancer Res; 2020 Mar 28; 40(3):1315-1323. PubMed ID: 32132028
    [Abstract] [Full Text] [Related]

  • 26. Oxidative cytotoxic agent withaferin A resensitizes temozolomide-resistant glioblastomas via MGMT depletion and induces apoptosis through Akt/mTOR pathway inhibitory modulation.
    Grogan PT, Sarkaria JN, Timmermann BN, Cohen MS.
    Invest New Drugs; 2014 Aug 28; 32(4):604-17. PubMed ID: 24718901
    [Abstract] [Full Text] [Related]

  • 27. DNA damage induced by temozolomide signals to both ATM and ATR: role of the mismatch repair system.
    Caporali S, Falcinelli S, Starace G, Russo MT, Bonmassar E, Jiricny J, D'Atri S.
    Mol Pharmacol; 2004 Sep 28; 66(3):478-91. PubMed ID: 15322239
    [Abstract] [Full Text] [Related]

  • 28. EMAP-II sensitize U87MG and glioma stem-like cells to temozolomide via induction of autophagy-mediated cell death and G2/M arrest.
    Yu Q, Liu L, Wang P, Yao Y, Xue Y, Liu Y.
    Cell Cycle; 2017 Jun 03; 16(11):1085-1092. PubMed ID: 28436750
    [Abstract] [Full Text] [Related]

  • 29. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
    Yu Z, Xie G, Zhou G, Cheng Y, Zhang G, Yao G, Chen Y, Li Y, Zhao G.
    Cancer Lett; 2015 Oct 10; 367(1):58-68. PubMed ID: 26188279
    [Abstract] [Full Text] [Related]

  • 30. The histone demethylase KDM5A is a key factor for the resistance to temozolomide in glioblastoma.
    Banelli B, Carra E, Barbieri F, Würth R, Parodi F, Pattarozzi A, Carosio R, Forlani A, Allemanni G, Marubbi D, Florio T, Daga A, Romani M.
    Cell Cycle; 2015 Oct 10; 14(21):3418-29. PubMed ID: 26566863
    [Abstract] [Full Text] [Related]

  • 31. Temozolomide Induces Senescence and Repression of DNA Repair Pathways in Glioblastoma Cells via Activation of ATR-CHK1, p21, and NF-κB.
    Aasland D, Götzinger L, Hauck L, Berte N, Meyer J, Effenberger M, Schneider S, Reuber EE, Roos WP, Tomicic MT, Kaina B, Christmann M.
    Cancer Res; 2019 Jan 01; 79(1):99-113. PubMed ID: 30361254
    [Abstract] [Full Text] [Related]

  • 32. Estrogen receptor beta enhances chemotherapy response of GBM cells by down regulating DNA damage response pathways.
    Zhou M, Sareddy GR, Li M, Liu J, Luo Y, Venkata PP, Viswanadhapalli S, Tekmal RR, Brenner A, Vadlamudi RK.
    Sci Rep; 2019 Apr 16; 9(1):6124. PubMed ID: 30992459
    [Abstract] [Full Text] [Related]

  • 33. Combination therapy of cold atmospheric plasma (CAP) with temozolomide in the treatment of U87MG glioblastoma cells.
    Gjika E, Pal-Ghosh S, Kirschner ME, Lin L, Sherman JH, Stepp MA, Keidar M.
    Sci Rep; 2020 Oct 05; 10(1):16495. PubMed ID: 33020527
    [Abstract] [Full Text] [Related]

  • 34. Effects of temozolomide (TMZ) on the expression and interaction of heat shock proteins (HSPs) and DNA repair proteins in human malignant glioma cells.
    Castro GN, Cayado-Gutiérrez N, Zoppino FC, Fanelli MA, Cuello-Carrión FD, Sottile M, Nadin SB, Ciocca DR.
    Cell Stress Chaperones; 2015 Mar 05; 20(2):253-65. PubMed ID: 25155585
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. In vitro and in vivo radiosensitization induced by the DNA methylating agent temozolomide.
    Kil WJ, Cerna D, Burgan WE, Beam K, Carter D, Steeg PS, Tofilon PJ, Camphausen K.
    Clin Cancer Res; 2008 Feb 01; 14(3):931-8. PubMed ID: 18245557
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Quercetin abrogates chemoresistance in melanoma cells by modulating deltaNp73.
    Thangasamy T, Sittadjody S, Mitchell GC, Mendoza EE, Radhakrishnan VM, Limesand KH, Burd R.
    BMC Cancer; 2010 Jun 11; 10():282. PubMed ID: 20540768
    [Abstract] [Full Text] [Related]

  • 39. Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells.
    Kanzawa T, Germano IM, Komata T, Ito H, Kondo Y, Kondo S.
    Cell Death Differ; 2004 Apr 11; 11(4):448-57. PubMed ID: 14713959
    [Abstract] [Full Text] [Related]

  • 40. Histone Deacetylase Inhibitor RGFP109 Overcomes Temozolomide Resistance by Blocking NF-κB-Dependent Transcription in Glioblastoma Cell Lines.
    Li ZY, Li QZ, Chen L, Chen BD, Wang B, Zhang XJ, Li WP.
    Neurochem Res; 2016 Dec 11; 41(12):3192-3205. PubMed ID: 27632183
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.